General MedicationsTOPICALGeneric
CLOBETASOL PROPIONATE
CLOBETASOL PROPIONATE
Standard Dose
0.05%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview CLOBETASOL PROPIONATE is listed in Drugs@FDA under application 214345 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient CLOBETASOL PROPIONATE Form and strength SPRAY;TOPICAL - 0.05% Sponsor MACLEODS PHARMS LTD Submission history Latest submission status date: 2024-12-02 00:00:00.
Structured Monograph
Clinical summary
Approval overview CLOBETASOL PROPIONATE is listed in Drugs@FDA under application 214345 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CLOBETASOL PROPIONATE Form and strength SPRAY;TOPICAL - 0.05% Sponsor MACLEODS PHARMS LTD Submission history Latest submission status date: 2024-12-02 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.